Your browser doesn't support javascript.
loading
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Camrelizumab Compared With Conventional Transarterial Chemoembolization Plus Camrelizumab for Unresectable Hepatocellular Carcinoma.
Ren, Yanqiao; Guo, Yusheng; Chen, Lei; Sun, Tao; Zhang, Weihua; Sun, Bo; Zhu, Licheng; Xiong, Fu; Zheng, Chuansheng.
  • Ren Y; Department of Radiology, 36630Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Guo Y; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
  • Chen L; Department of Radiology, 36630Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Sun T; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
  • Zhang W; Department of Radiology, 36630Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Sun B; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
  • Zhu L; Department of Radiology, 36630Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xiong F; Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
  • Zheng C; Department of Radiology, 36630Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cancer Control ; 29: 10732748221076806, 2022.
Article en En | MEDLINE | ID: mdl-35343254

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article